Zollinger-Ellison syndrome: recent advances and controversies. - Wikidata - awgldk - TriplyDB

Zollinger-Ellison syndrome: recent advances and controversies.

Zollinger-Ellison syndrome: recent advances and controversies.

http://www.wikidata.org/entity/Q38150165

about

Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression Signs and genetics of rare cancer syndromes with gastroenterological features.Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.

P2860

Q30435359-238D230B-459B-450C-97E4-347D7C70819B Q35713515-D1C63BE3-0FF6-41E5-A024-1CB1D0FC0632 Q36849357-C6E26FAF-6D80-4158-A167-3B55F98AE5F2 Q38646393-0E5B864A-FE49-4A3F-955F-901C0C18ADB5 Q38956091-4A98E6D7-00C2-4195-9326-5931E369ABCD Q41458940-FA698FF3-2180-42FB-AACE-A10F822E9248 Q42371575-36E9AEAF-9223-40B2-8652-DE0F7EBF1F21 Q42434480-D5E0E54C-BA61-46F2-943D-DB9C6B20D73C Q43066318-87E98377-871E-4181-9DCD-9D4F480CB243 Q47724538-EC98E620-F957-4F5A-A494-4D92ED4DFD02 Q47822235-23AFCAF5-F0A5-49B5-A129-A2E00D5A3016 Q50075239-AD043CD0-8A2C-448C-97CF-7BCA5A7C936A Q54638848-E600170B-BF54-4E9A-AB43-A60AED661558

P2860

Zollinger-Ellison syndrome: recent advances and controversies.

http://www.wikidata.org/entity/Q38150165

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Zollinger-Ellison syndrome: recent advances and controversies.

@en

type

label

Zollinger-Ellison syndrome: recent advances and controversies.

@en

prefLabel

Zollinger-Ellison syndrome: recent advances and controversies.

@en

P1433

Q38150165-9EF04E5C-F776-48A1-A774-F686948558EB

P1476

Q38150165-5F6CBFB4-B8C5-4CE0-89FE-C393FAD5C302

P2093

Q38150165-9E76BA08-FF8D-4DA1-94B0-E4801AC9E6CA

Q38150165-A5996A71-AE99-4A9A-9B2A-8D450CFEA55E

Q38150165-B4989EA2-ACB3-45FF-BC7E-6BD20E51A5C6

P2860

Q38150165-00E9771D-E4CA-4680-AD57-5334CDD8CC93

Q38150165-0305A9B2-ADA8-4C12-AE78-8B66B2056F9C

Q38150165-03F64BCD-10EA-4046-B723-F70CEE526560

Q38150165-04351492-5C35-4643-83C0-2CDF082630F0

Q38150165-05C57BD4-7EE7-4158-907C-B1515A862C7E

Q38150165-07E4334E-DA03-47A1-9DEA-9FFB569C895F

Q38150165-0988BECF-FA61-4F0E-B9E3-AC17A6CAA53A

Q38150165-0A5348CF-4A07-4F36-B242-3892CFF71811

Q38150165-0B9D97F3-DAE9-4990-9431-A1FB9D2840E7

Q38150165-0C7D28E5-B980-4826-A2B5-844E1A094D04

P304

Q38150165-D8F5A0E9-514A-4825-94CD-E9A7318FBEAA

P31

Q38150165-EEC121DE-F782-4A40-A1ED-46B9DDDE4533

P356

Q38150165-FB9BADE8-8A60-4610-AB63-1AE6C82DFDC5

P433

Q38150165-2A39B273-4427-4E02-8117-1B8B328F8966

P478

Q38150165-01215299-DDAC-4144-BE2B-8FF0A695E2EE

P577

Q38150165-A1F00363-D29D-4591-B834-2D35B4B0B092

P698

Q38150165-5CDF5512-812C-44CA-9F53-48152FB940AA

P932

Q38150165-E8AB722F-D7A6-4B60-AE28-5558FB2F4656

P356

MOG.0B013E328365EFB1

P1433

Current Opinion in Gastroenterology

P1476

Zollinger-Ellison syndrome: recent advances and controversies.

@en

P2093

Hisato Igarashi

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

Tetsuhide Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

Primary hepatic gastrinoma: an unusual case of zollinger-ellison syndrome.

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary.

Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium

Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway.

P304

650-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MOG.0B013E328365EFB1

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24100728

http://www.w3.org/2001/XMLSchema#string

P932

5555311

http://www.w3.org/2001/XMLSchema#string